-
Mashup Score: 8ClinicalTrials.gov - 4 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 34Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review - 5 month(s) ago
Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review
Source: jgo.amegroups.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Co-occurrent KRAS and TP53 mutations define a majority of patients with pancreatic ductal adenocarcinoma (PDAC) and define its pro-metastatic proclivity. Here, we demonstrate that KRAS-TP53 co-alteration is associated with worse survival compared with either KRAS-alone or TP53-alone altered PDAC in …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Cherishing the Simple Things - 1 year(s) ago
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Source: Let's Win! Pancreatic CancerCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Immunotherapy Study Offers Hope for Pancreatic Cancer Patients - 2 year(s) ago
In a research letter to the journal JAMA Oncology, clinical researchers at Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine showed that immunotherapy can be an option for at least one subgroup of pancreatic cancer patients. The study found that patients…
Categories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Cherishing the Simple Things - 2 year(s) ago
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Source: Let's Win! Pancreatic CancerCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 13Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With HRD PGVs - 2 year(s) ago
This case series describes ipilimumab/nivolumab therapy in patients with metastatic pancreatic or biliary cancer with homologous recombination deficiency (HRD) pathogenic germline variants (PGVs).
Source: jamanetwork.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 5
Please join us for our first international virtual pancreatic cancer symposium on January 28th, 2022. This symposium brings together pancreatic cancer experts to provide the most up-to-date information on the diagnosis, staging, and state-of-the-art treatments. See below for a PDF Agenda with all topics and speakers.Speakers: – Peter Hosein, MD, University of Miami: Making Inroads into…
Source: ocpe.mcw.eduCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Array - 3 year(s) ago
Activty Title The event will begin on Event Date and Time Session join buttons will be made available shortly before the event’s start time
Source: control.arraylive.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 7HOME - Sylvester Cancer Center Annual Oncology Update 2021 - 3 year(s) ago
This educational activity will provide participants with an overview of the most up-to-date research and clinical advances in oncology.
Source: event.onclive.comCategories: Latest Headlines, Oncologists2Tweet
First: Trials in progress Poster on our IIT testing MEK, STAT3 and PD1 inhibition in metastatic pancreas cancer https://t.co/aMTGb1ziVW https://t.co/kEjy4NKYf3